These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1299271)

  • 1. Inhibition of mammalian ribonucleotide reductase by cis-diamminedichloroplatinum(II).
    Chiu CS; Chan AK; Wright JA
    Biochem Cell Biol; 1992 Dec; 70(12):1332-8. PubMed ID: 1299271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase, and the significance to DNA synthesis.
    Wright JA; Chan AK; Choy BK; Hurta RA; McClarty GA; Tagger AY
    Biochem Cell Biol; 1990 Dec; 68(12):1364-71. PubMed ID: 2085432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered regulation of message stability and tumor promoter-responsive cis-trans interactions of ribonucleotide reductase R1 and R2 messenger RNAs in hydroxyurea-resistant cells.
    Amara FM; Hurta RA; Huang A; Wright JA
    Cancer Res; 1995 Oct; 55(20):4503-6. PubMed ID: 7553616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between levels of ferritin and the iron-containing component of ribonucleotide reductase in hydroxyurea-sensitive, -resistant, and -revertant cell lines.
    Hurta RA; Wright JA
    Biochem Cell Biol; 1991 Sep; 69(9):635-42. PubMed ID: 1793565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations.
    Choy BK; McClarty GA; Chan AK; Thelander L; Wright JA
    Cancer Res; 1988 Apr; 48(8):2029-35. PubMed ID: 2832057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and initial characterization of a series of Chlamydia trachomatis isolates selected for hydroxyurea resistance by a stepwise procedure.
    Tipples G; McClarty G
    J Bacteriol; 1991 Aug; 173(16):4932-40. PubMed ID: 1860812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability.
    Huang A; Fan H; Taylor WR; Wright JA
    Cancer Res; 1997 Nov; 57(21):4876-81. PubMed ID: 9354452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the activity and regulation of mammalian ribonucleotide reductase by chlorambucil, a DNA damaging agent.
    Hurta RA; Wright JA
    J Biol Chem; 1992 Apr; 267(10):7066-71. PubMed ID: 1551913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of the genes for both components of ribonucleotide reductase in hydroxyurea resistant mammalian cells.
    Hurta RA; Wright JA
    Biochem Biophys Res Commun; 1990 Feb; 167(1):258-64. PubMed ID: 2178608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversion of hydroxyurea resistance, decline in ribonucleotide reductase activity, and loss of M2 gene amplification.
    McClarty GA; Chan AK; Choy BK; Wright JA
    Biochem Biophys Res Commun; 1987 Jun; 145(3):1276-82. PubMed ID: 3300645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.
    Terheggen PM; Emondt JY; Floot BG; Dijkman R; Schrier PI; den Engelse L; Begg AC
    Cancer Res; 1990 Jun; 50(12):3556-61. PubMed ID: 2340504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyurea-resistant mouse L cells with elevated levels of drug-resistant ribonucleotide reductase activity.
    Kuzik BA; Wright JA
    Biochem Genet; 1980 Apr; 18(3-4):311-31. PubMed ID: 7004438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.
    Finch RA; Liu M; Grill SP; Rose WC; Loomis R; Vasquez KM; Cheng Y; Sartorelli AC
    Biochem Pharmacol; 2000 Apr; 59(8):983-91. PubMed ID: 10692563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A series of N-carbamoyloxyurea resistant cell lines with alterations in ribonucleotide reductase: lack of coordination in pyrimidine and purine reductase activity.
    Hards RG; Wright JA
    Can J Biochem Cell Biol; 1983; 61(2-3):120-9. PubMed ID: 6342725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribonucleotide reductase: an intracellular target for the male antifertility agent, gossypol.
    McClarty GA; Chan AK; Creasey DC; Wright JA
    Biochem Biophys Res Commun; 1985 Nov; 133(1):300-5. PubMed ID: 3907637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective, strong inhibition of ribonucleotide reductase from E. coli by cisplatin.
    Smith SL; Douglas KT
    Biochem Biophys Res Commun; 1989 Jul; 162(2):715-23. PubMed ID: 2667519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms responsible for the drug-induced posttranscriptional modulation of ribonucleotide reductase levels in a hydroxyurea-resistant mouse L cell line.
    McClarty GA; Chan AK; Choy BK; Thelander L; Wright JA
    Biochemistry; 1988 Sep; 27(19):7524-31. PubMed ID: 3061459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea-induced conversion of mammalian ribonucleotide reductase to a form hypersensitive to bleomycin.
    McClarty GA; Chan AK; Wright JA
    Cancer Res; 1986 Sep; 46(9):4516-21. PubMed ID: 2425956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of ribonucleotide reductase and role of M2 gene amplification in hydroxyurea-resistant hamster, mouse, rat, and human cell lines.
    Wright JA; Alam TG; McClarty GA; Tagger AY; Thelander L
    Somat Cell Mol Genet; 1987 Mar; 13(2):155-65. PubMed ID: 3551113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of malignancy by the 3' untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs.
    Fan H; Villegas C; Huang A; Wright JA
    Cancer Res; 1996 Oct; 56(19):4366-9. PubMed ID: 8813126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.